Stroke of an undetermined cause was associated with acute symptomatic seizures, an effect that was marginally mediated by cerebral microbleeds.
This article was originally published on Neurology Live. It has been lightly edited.
Findings from a retrospective study of hospitalized patients with anterior circulation ischemic stroke showed an association between cerebral microbleeds (CMBs) and acute symptomatic seizures (ASS). However, this connection was attenuated after accounting for multiple different covariates.
The study is published in Epilepsy & Behavior.
"The presence of CMB alone would be insufficient to explain the onset of seizures after stroke as this is a gradual process, reflecting the prolonged effects of stroke risk factors on cerebral small vessels," lead author Alain Z. Looti, MD, MS, assistant professor, Penn State Neuroscience Institute, and colleagues, wrote. "The presence of cerebral microbleeds may thus indicate a patient with greater risk factors for stroke and thus more likely to have a more severe stroke. Stroke severity, which is associated with an increased risk of seizures, could therefore potentially mediate the relationship between CMB and seizures."
Alain Z. Looti, MD, MS, assistant professor, Penn State Neuroscience Institute
Among a cohort of 381 participants, 17 (4.4%) patients had seizures during hospitalization after the index stroke. On an univariable analysis, the presence of 4 or more CMBs (odds ratio [OR], 3.84; 95% CI, 1.16-12.71) and stroke etiologies were associated with ASS. After adjusting for confounders such as stroke severity, cortical infarct location, and hemorrhagic transformation, the association between CMBs and ASS was reduced (adjusted OR, 3.11; 95% CI, 0.74-11.03; P = .09).
In this single center study, multivariable logistic regression analysis showed that patients with a stroke of undetermined cause were found to be more likely to have ASS (adjusted OR, 5.09; 95% CI, 1.17-35.25; P = .05). A summary of ASS characteristics revealed that time to seizure after stroke was less than 1 day in 71% of the cases, 47% of the ASS were focal, status epilepticus was observed in 6%, and most patients had started on levetiracetam. In causal mediation analysis, findings showed that the effect of CMB on ASS was not mediated by stroke severity.
In terms of the association between cryptogenic strokes and ASS, investigators noted that “establishing causality would be hazardous in the absence of solid biological plausibility and confirmation by other studies.” They continued that confirmatory evidence should come from prospective analyses accounting for the association between cryptogenic strokes, cortical infarcts, and their characteristics.
The study had several limitations, including the fact that seizures were reported by clinicians, with 94% of patients having diagnosis supported by an electroencephalography. In addition, the cohort was limited to patients with anterior circulation stroke, precluding the generalizability of the results to all patients with stroke. Furthermore, there was no information about the localization of CMB relative to seizure onset, as this would have required that all seizures be captured during a continuous electroencephalogram monitoring, which was beyond the scope of the analysis.
Reference
Lekoubou A, Ssentongo P, Maffie J, et al. Associations of small vessel disease and acute symptomatic seizures in ischemic stroke patients. Epilepsy Behav. 2023;145:109233. doi:10.1016/j.yebeh.2023.109233
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
No Major Shifts in OBGYN Practice Locations Found Post Dobbs Decision
April 21st 2025Despite widespread concern following the Dobbs v Jackson Women’s Health Organization decision, researchers found no significant changes nationwide in obstetrician and gynecologist (OBGYN) practice locations.
Read More